Cargando…
Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement
Since their introduction in clinical practice in the 1950's, Sulfonylureas (SUs) have remained the main-stay of pharmacotherapy in the management of type 2 diabetes. Despite their well-established benefits, their place in therapy is inappropriately being overshadowed by newer therapies. Many of...
Autores principales: | Kalra, Sanjay, Aamir, A. H., Raza, Abbas, Das, A. K., Azad Khan, A. K., Shrestha, Dina, Qureshi, Md Faisal, Md Fariduddin, Pathan, Md Faruque, Jawad, Fatema, Bhattarai, Jyoti, Tandon, Nikhil, Somasundaram, Noel, Katulanda, Prasad, Sahay, Rakesh, Dhungel, Sanjib, Bajaj, Sarita, Chowdhury, Subhankar, Ghosh, Sujoy, Madhu, S. V., Ahmed, Tofail, Bulughapitiya, Uditha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566336/ https://www.ncbi.nlm.nih.gov/pubmed/26425465 http://dx.doi.org/10.4103/2230-8210.163171 |
Ejemplares similares
-
The Dhaka Declaration 2015
por: Mahtab, Hajera, et al.
Publicado: (2015) -
Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force
por: Kalra, Sanjay, et al.
Publicado: (2018) -
Sulfonylureas: Assets in the past, present and future
por: Kalra, Sanjay, et al.
Publicado: (2015) -
Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement
por: Kalra, Sanjay, et al.
Publicado: (2017) -
Sulfonylureas at the Glomerular Battlefield
por: Kalra, Sanjay, et al.
Publicado: (2018)